Literature DB >> 23651015

Implementation of a clinical research pharmacogenomics program at an academic medical center: role of the genetics healthcare professional.

Amy Curry Sturm, Kevin Sweet, Kandamurugu Manickam.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 23651015      PMCID： PMC3796352          DOI： 10.2217/pgs.13.46

Source DB:  PubMed          Journal:  Pharmacogenomics        ISSN： 1462-2416            Impact factor:   2.533


× No keyword cloud information.
  19 in total

1.  CPIC: Clinical Pharmacogenetics Implementation Consortium of the Pharmacogenomics Research Network.

Authors:  M V Relling; T E Klein
Journal:  Clin Pharmacol Ther       Date:  2011-01-26       Impact factor: 6.875

2.  The prospect of genome-guided preventive medicine: a need and opportunity for genetic counselors.

Authors:  Julianne M O'Daniel
Journal:  J Genet Couns       Date:  2010-05-04       Impact factor: 2.537

3.  Practical recommendations for pharmacogenomics-based prescription: 2010 ESF-UB Conference on Pharmacogenetics and Pharmacogenomics.

Authors:  Laurent Becquemont; Ana Alfirevic; Ursula Amstutz; Hiltrud Brauch; Evelyne Jacqz-Aigrain; Pierre Laurent-Puig; Miguel A Molina; Mikko Niemi; Matthias Schwab; Andrew A Somogyi; Eric Thervet; Anke-Hilse Maitland-van der Zee; André Bp van Kuilenburg; Ron Hn van Schaik; Céline Verstuyft; Mia Wadelius; Ann K Daly
Journal:  Pharmacogenomics       Date:  2011-01       Impact factor: 2.533

4.  Direct-to-consumer personal genomic testing: a case study and practical recommendations for “genomic counseling”.

Authors:  Amy C Sturm; Kandamurugu Manickam
Journal:  J Genet Couns       Date:  2012-06       Impact factor: 2.537

5.  Survey of genetic counselors and clinical geneticists' use and attitudes toward pharmacogenetic testing.

Authors:  S B Haga; J M O'Daniel; G M Tindall; R Mills; I M Lipkus; R Agans
Journal:  Clin Genet       Date:  2012-02-19       Impact factor: 4.438

Review 6.  Ancillary risk information and pharmacogenetic tests: social and policy implications.

Authors:  N B Henrikson; W Burke; D L Veenstra
Journal:  Pharmacogenomics J       Date:  2007-05-08       Impact factor: 3.550

7.  Primary care physicians' knowledge of and experience with pharmacogenetic testing.

Authors:  S B Haga; W Burke; G S Ginsburg; R Mills; R Agans
Journal:  Clin Genet       Date:  2012-07-03       Impact factor: 4.438

8.  Pharmacogenomics in the pocket of every patient? A prototype based on quick response codes.

Authors:  Matthias Samwald; Klaus-Peter Adlassnig
Journal:  J Am Med Inform Assoc       Date:  2013-01-23       Impact factor: 4.497

9.  The dawning era of personalized medicine exposes a gap in medical education.

Authors:  Keyan Salari
Journal:  PLoS Med       Date:  2009-08-25       Impact factor: 11.069

Review 10.  Mapping the incidentalome: estimating incidental findings generated through clinical pharmacogenomics testing.

Authors:  Matthew J Westbrook; M Frances Wright; Sara L Van Driest; Tracy L McGregor; Joshua C Denny; Rebecca L Zuvich; Ellen Wright Clayton; Kyle B Brothers
Journal:  Genet Med       Date:  2012-11-29       Impact factor: 8.822
View more
  8 in total

1.  Impact of SLCO1B1 Pharmacogenetic Testing on Patient and Healthcare Outcomes: A Systematic Review.

Authors:  Jason L Vassy; Sojeong Chun; Sanjay Advani; Sophie A Ludin; Jason G Smith; Elaine C Alligood
Journal:  Clin Pharmacol Ther       Date:  2018-10-18       Impact factor: 6.875

Review 2.  Progress towards the integration of pharmacogenomics in practice.

Authors:  Sean D Mooney
Journal:  Hum Genet       Date:  2014-09-11       Impact factor: 4.132

3.  Clinical pharmacogenomics: patient perspectives of pharmacogenomic testing and the incidence of actionable test results in a chronic disease cohort.

Authors:  Chandrama Mukherjee; Kevin M Sweet; Jasmine A Luzum; Mahmoud Abdel-Rasoul; Michael F Christman; Joseph P Kitzmiller
Journal:  Per Med       Date:  2017-09-01       Impact factor: 2.512

4.  The Pharmacogenomics Research Network Translational Pharmacogenetics Program: Outcomes and Metrics of Pharmacogenetic Implementations Across Diverse Healthcare Systems.

Authors:  J A Luzum; R E Pakyz; A R Elsey; C E Haidar; J F Peterson; M Whirl-Carrillo; S K Handelman; K Palmer; J M Pulley; M Beller; J S Schildcrout; J R Field; K W Weitzel; R M Cooper-DeHoff; L H Cavallari; P H O'Donnell; R B Altman; N Pereira; M J Ratain; D M Roden; P J Embi; W Sadee; T E Klein; J A Johnson; M V Relling; L Wang; R M Weinshilboum; A R Shuldiner; R R Freimuth
Journal:  Clin Pharmacol Ther       Date:  2017-06-09       Impact factor: 6.875

5.  Perspectives on genetic and genomic technologies in an academic medical center: the duke experience.

Authors:  Sara Huston Katsanis; Mollie A Minear; Allison Vorderstrasse; Nancy Yang; Jason W Reeves; Tejinder Rakhra-Burris; Robert Cook-Deegan; Geoffrey S Ginsburg; Leigh Ann Simmons
Journal:  J Pers Med       Date:  2015-04-03

6.  Design and implementation of a randomized controlled trial of genomic counseling for patients with chronic disease.

Authors:  Kevin Sweet; Erynn S Gordon; Amy C Sturm; Tara J Schmidlen; Kandamurugu Manickam; Amanda Ewart Toland; Margaret A Keller; Catharine B Stack; J Felipe García-España; Mark Bellafante; Neeraj Tayal; Peter Embi; Philip Binkley; Ray E Hershberger; Wolfgang Sadee; Michael Christman; Clay Marsh
Journal:  J Pers Med       Date:  2014-01-08

Review 7.  Pharmacogenomic testing in paediatrics: Clinical implementation strategies.

Authors:  Charlotte I S Barker; Gabriella Groeneweg; Anke H Maitland-van der Zee; Michael J Rieder; Daniel B Hawcutt; Tim J Hubbard; Jesse J Swen; Bruce C Carleton
Journal:  Br J Clin Pharmacol       Date:  2022-02-07       Impact factor: 3.716

Review 8.  Benefit of Preemptive Pharmacogenetic Information on Clinical Outcome.

Authors:  Dan M Roden; Sara L Van Driest; Jonathan D Mosley; Quinn S Wells; Jamie R Robinson; Joshua C Denny; Josh F Peterson
Journal:  Clin Pharmacol Ther       Date:  2018-03-13       Impact factor: 6.875
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.